PORT VILA,Vanuatu,March 17,2025-- Vantage Markets participated as a Titanium Sponsor at Money Expo Mexico 2025,held on February 26-27. The event,known as one of the most significant gatherings for tr
TORONTO,March 17,2025-- Visionary Holdings Inc (NASDAQ: GV,hereinafter referred to as "Visionary") has made a significant announcement. The company has taken a milestone and crucial step in
BRIDGETOWN,Barbados,March 17,2025-- The SEforALL Global Forum has witnessed groundbreaking commitments totalling over USD 900 million to scale energy access and drive the clean energy transition. Mor
Glowmode and Nature Dream Bali Come Together to Create a Nature-Inspired Collection with Female Empowerment and Mindfulness in Mind
TORONTO,March 17,2025-- Visionary Holdings Inc (NASDAQ: GV,hereinafter referred to as "Visionary") has made a significant announcement. The company has taken a milestone and crucial step in
MELBOURNE,Australia andPORTO ALEGRE,Brazil,March 18,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company)today announces that the Brazilian Health Regulatory Agency (Agencia N
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening
HONG KONG,March 17,2025-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Caofeidian 6-4 Oilfield Comprehensive Adjustment P
Batoclimab receives Orphan Drug Designation in Japan,advancing treatment for active Thyroid Eye Disease (TED).
SHANGHAI,March 13,2025-- BioCity Biopharmaceutics Co.,Ltd.,a clinical-stage biopharmaceutical company,today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck
BANGKOK,March 13,2025-- Thailand\'s Commission on the National Competitiveness Enhancement for Targeted Industries,at a meeting today,approved an investment by a unit of China\'sSunwoda Electronic wor
HONG KONG,March 13,2025-- Cybersecurity training in the Asia Pacific region is set to be enhanced with an agreement signed today between the APNIC Foundation and ISC2.
© OfficialAffairs
